Systemic Lupus Erythematosus

expert roundtables by Bevra H. Hahn, MD; Joan T. Merrill, MD; and George C. Tsokos, MD

Treat-to-target strategies in systemic lupus erythematosus (SLE) involve setting the treatment target to complete remission or to low disease activ......READ MORE

Systemic Lupus Erythematosus

expert roundtables by Bevra H. Hahn, MD; Joan T. Merrill, MD; and George C. Tsokos, MD

Treatment goals in systemic lupus erythematosus (SLE) include achieving long-term patient survival, preventing flares and organ damage, and safegua......READ MORE

Systemic Lupus Erythematosus

patient care perspectives by George C. Tsokos, MD

Low-dose interleukin-2 (IL-2) therapy continues to be studied as a potential approach for systemic lupus erythematosus (SLE), where it may restore ......READ MORE

Systemic Lupus Erythematosus

clinical topic updates by Joan T. Merrill, MD

Many patients with systemic lupus erythematosus (SLE) have high levels of type I interferon (IFN)–regulated genes in peripheral blood, known as the......READ MORE

Systemic Lupus Erythematosus

expert roundtables by Bevra H. Hahn, MD; Joan T. Merrill, MD; and George C. Tsokos, MD

There have been 2 recent additions to the therapeutic landscape in systemic lupus erythematosus (SLE), with voclosporin and belimumab both showing ......READ MORE